What is the recommended approach to evaluate and manage metabolic acidosis in a patient?

Metabolic Acidosis: Evaluation and Management

Initial Diagnostic Approach

The first step in evaluating metabolic acidosis is to confirm the diagnosis with arterial or venous blood gas showing pH <7.35 and serum bicarbonate <22 mmol/L, then immediately calculate the anion gap to categorize the acidosis. 1

Calculate the Anion Gap

• Anion gap = Na⁺ − (HCO₃⁻ + Cl⁻), with normal values of 10–12 mEq/L 1
• An anion gap >12 mEq/L indicates accumulation of unmeasured anions such as lactate, ketoacids, uremic toxins, or ingested toxins 1, 2
• Normal anion gap (hyperchloremic) acidosis suggests bicarbonate loss from the GI tract (diarrhea) or renal tubular acidosis 1, 3

Essential Laboratory Studies

• Obtain serum electrolytes (Na⁺, K⁺, Cl⁻, HCO₃⁻), glucose, BUN, creatinine, and lactate to identify the underlying cause 1, 3
• Measure serum and urine ketones if diabetic ketoacidosis is suspected (glucose >250 mg/dL with positive ketones) 1
• Check urine pH to help differentiate causes of normal anion gap acidosis 3
• Venous pH is typically ~0.03 units lower than arterial pH and can be used for ongoing monitoring after initial diagnosis, eliminating the need for repeated arterial punctures 1

---

High Anion Gap Metabolic Acidosis

Common Causes (Use Mnemonic: GOLDMARK)

• Glycols (ethylene glycol, propylene glycol)
• Oxoproline (5-oxoproline from chronic acetaminophen use)
• L-lactate (tissue hypoperfusion, sepsis, seizures)
• D-lactate (short bowel syndrome)
• Methanol
• Aspirin (salicylate toxicity)
• Renal failure (uremic acidosis)
• Ketoacidosis (diabetic, alcoholic, starvation) 2, 3

Management of Diabetic Ketoacidosis (DKA)

The cornerstone of DKA therapy is intravenous insulin combined with aggressive fluid resuscitation; bicarbonate is NOT indicated unless pH falls below 6.9–7.0. 1, 4

Initial Resuscitation

• Administer isotonic saline (0.9% NaCl) at 15–20 mL/kg/h during the first hour to restore intravascular volume 1, 4
• After confirming serum potassium >3.3 mEq/L, start continuous IV regular insulin at 0.1 U/kg/h 1
• Add 20–30 mEq/L potassium (2/3 KCl and 1/3 KPO₄) to maintenance fluids once urine output is established 1

Bicarbonate Use in DKA

• Bicarbonate is NOT recommended when pH ≥7.0 because insulin therapy alone resolves the acidosis 1, 4
• For pH 6.9–7.0: Give 50 mmol sodium bicarbonate in 200 mL sterile water at 200 mL/h 1, 4
• For pH <6.9: Give 100 mmol sodium bicarbonate in 400 mL sterile water at 200 mL/h 1, 4

Monitoring

• Check venous pH and anion gap every 2–4 hours to assess resolution 1
• Monitor serum potassium every 2–4 hours because insulin and alkalinization drive potassium intracellularly, risking life-threatening hypokalemia 1, 4
• DKA resolution criteria: glucose <200 mg/dL, bicarbonate ≥18 mEq/L, and venous pH ≥7.3 1

Management of Lactic Acidosis

Do NOT administer sodium bicarbonate for hypoperfusion-induced lactic acidemia when pH ≥7.15, as two randomized controlled trials showed no hemodynamic benefit and potential harm. 1, 4

• Focus on treating the underlying cause: restore tissue perfusion with fluid resuscitation and vasopressors in sepsis 1, 4
• Bicarbonate may be considered only when pH <7.0–7.1 after optimizing ventilation and hemodynamics 4
• Adverse effects of bicarbonate in lactic acidosis include: sodium/fluid overload, increased lactate production, elevated PaCO₂, and decreased ionized calcium 4, 5

---

Normal Anion Gap (Hyperchloremic) Metabolic Acidosis

Common Causes

• Diarrhea (most common cause of bicarbonate loss) 1, 3
• Renal tubular acidosis (Types 1,2, and 4) 3
• Ureterosigmoidostomy or ileal conduit 3
• Recovery phase of diabetic ketoacidosis 1
• Large-volume 0.9% saline administration (iatrogenic hyperchloremic acidosis) 1

Management

• Treat the underlying cause: rehydration for diarrhea, discontinue offending medications 1
• Replace 0.9% saline with balanced crystalloid solutions (Lactated Ringer's or Plasma-Lyte) to avoid additional chloride loading 1
• Oral sodium bicarbonate 2–4 g/day (25–50 mEq/day) may be needed for chronic conditions like renal tubular acidosis 1, 4

---

Chronic Kidney Disease-Related Metabolic Acidosis

Maintain serum bicarbonate ≥22 mmol/L in CKD patients to prevent protein catabolism, bone disease, and CKD progression. 1, 6

Treatment Algorithm Based on Bicarbonate Level

• Bicarbonate ≥22 mmol/L: Monitor every 3 months; no pharmacologic intervention needed 1
• Bicarbonate 18–22 mmol/L: Consider oral sodium bicarbonate 0.5–1.0 mEq/kg/day in 2–3 divided doses, plus dietary intervention (increase fruits and vegetables) 1
• Bicarbonate <18 mmol/L: Initiate oral sodium bicarbonate 2–4 g/day (25–50 mEq/day) divided into 2–3 doses 1, 6

Monitoring

• Check serum bicarbonate monthly until stable, then every 3–4 months 1
• Monitor blood pressure, serum potassium, and fluid status regularly to ensure treatment doesn't cause hypertension or hyperkalemia 1

Clinical Benefits of Correction

• Reduces protein catabolism and muscle wasting by decreasing oxidation of branched-chain amino acids 1, 6
• Prevents bone demineralization and reduces secondary hyperparathyroidism 1, 6
• Slows CKD progression and may delay the need for dialysis 1
• Increases serum albumin and promotes weight gain 1, 6

Dietary Approach

• Increasing fruit and vegetable intake provides potassium citrate salts that generate alkali, reduces net acid production, and may decrease systolic blood pressure and body weight 1
• Avoid citrate-containing alkali in CKD patients exposed to aluminum salts (e.g., aluminum-containing phosphate binders), as citrate increases aluminum absorption 1

---

Severe Metabolic Acidosis (pH <7.1)

Sodium bicarbonate should be administered only when arterial pH is <7.1 AND base excess is ≤−10 mmol/L, and only after ensuring adequate ventilation to eliminate the CO₂ generated. 1, 4

Indications for IV Sodium Bicarbonate

• Severe metabolic acidosis with pH <7.1 and base deficit <−10 mmol/L 1, 4
• Life-threatening hyperkalemia (as a temporizing measure while definitive therapy is initiated) 1, 4
• Tricyclic antidepressant or sodium channel blocker overdose with QRS >120 ms, targeting pH 7.45–7.55 1, 4
• Cardiac arrest after first epinephrine dose fails with documented pH <7.1 1, 4

Dosing

• Initial dose: 1–2 mEq/kg IV (typically 50–100 mEq or 50–100 mL of 8.4% solution) given slowly over several minutes 1, 4
• Repeat dosing: 50 mEq every 5–10 minutes as guided by arterial blood gas monitoring 1, 4
• Target pH: 7.2–7.3 (avoid overshooting >7.5) 1, 4

Critical Monitoring

• Arterial blood gases every 2–4 hours to assess pH, PaCO₂, and bicarbonate response 1, 4
• Serum electrolytes every 2–4 hours: monitor sodium (target <150–155 mEq/L), potassium, and ionized calcium 1, 4
• Ensure adequate ventilation before and during bicarbonate administration to eliminate CO₂; aim for PaCO₂ 30–35 mmHg 1, 4

Adverse Effects to Monitor

• Hypernatremia and hyperosmolarity from sodium load 4, 5
• Hypokalemia from intracellular potassium shift; replace as needed 1, 4
• Hypocalcemia (decreased ionized calcium) affecting cardiac contractility 4, 5
• Paradoxical intracellular acidosis if ventilation is inadequate to clear CO₂ 4, 5
• Fluid overload in patients with renal impairment or heart failure 4

---

Special Clinical Scenarios

Cardiac Arrest

• Routine bicarbonate use is NOT recommended in cardiac arrest, as it does not improve survival 1, 4
• Consider bicarbonate only after first epinephrine dose fails and documented pH <7.1 is present 1, 4
• Dose: 1–2 mEq/kg (44.6–100 mEq) as rapid IV bolus; repeat every 5–10 minutes if pH remains low 1, 4

Rhabdomyolysis with Myoglobinuria

• Use bicarbonate to alkalinize urine (target urine pH >6.5) and prevent acute tubular necrosis 4
• Maintain urine output >2 mL/kg/h with aggressive fluid resuscitation 4

Tumor Lysis Syndrome

• Bicarbonate is indicated only for documented metabolic acidosis, not for prophylaxis 4
• Avoid bicarbonate if uric acid is elevated, as alkaline urine promotes uric acid precipitation 4

---

Common Pitfalls to Avoid

• Never give bicarbonate without ensuring adequate ventilation, as this worsens intracellular acidosis 1, 4, 5
• Do not treat pH ≥7.15 in lactic or septic acidosis with bicarbonate; evidence shows no benefit and possible harm 1, 4
• Do not mix bicarbonate with calcium-containing solutions or vasoactive amines (causes precipitation or inactivation) 4
• Do not ignore potassium levels; bicarbonate shifts potassium intracellularly and can precipitate life-threatening hypokalemia 1, 4
• Bicarbonate does not replace definitive therapy; always treat the underlying cause (restore perfusion, give insulin for DKA, etc.) 1, 4, 5
• Avoid large-volume 0.9% saline, which can cause iatrogenic hyperchloremic acidosis; use balanced crystalloids instead 1

---

Indications for Hospitalization (CKD Patients)

• Bicarbonate <18 mmol/L requiring pharmacological treatment and close monitoring 1
• Acute illness or catabolic state (critical illness, major surgery, acute kidney injury) 1
• Symptomatic complications: severe muscle weakness, altered mental status, inability to maintain oral intake 1
• Severe electrolyte disturbances: hyperkalemia, severe hypocalcemia 1
• Need for kidney replacement therapy initiation 1